Vanessa M Beutgen

9PUBLICATIONS
27CO-AUTHORS
Molecular targetsAutoimmunityPredictive and prognostic markersCharacterisation of biological macromoleculesImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 23, 2025
Synergistic targeting of cancer cells through simultaneous inhibition of key metabolic enzymes.

Jan Dreute, Julia Stengel, Jonas Becher

|Dec 17, 2024
Correlation of Functional and Structural Outcomes with Serum Antibody Profiles in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab and Healthy Subjects: A Prospective, Controlled Monocenter Trial.

Christina A Korb, Eva Gerstenberger, Katrin Lorenz

|Jun 28, 2024
BAG6 restricts pancreatic cancer progression by suppressing the release of IL33-presenting extracellular vesicles and the activation of mast cells.

Bilal Alashkar Alhamwe, Viviane Ponath, Fahd Alhamdan

|May 29, 2024
Sample-Treatment with the Virucidal β-Propiolactone Does Not Preclude Analysis by Large Panel Affinity Proteomics, Including the Discovery of Biomarker Candidates.

Vanessa M Beutgen, Aditya M Bhagwat, Anna Mary Steitz

|Apr 03, 2024
Reciprocal crosstalk between Th17 and mesothelial cells promotes metastasis-associated adhesion of ovarian cancer cells.

Felix Neuhaus, Sonja Lieber, Veronika Shinkevich

|Apr 23, 2022
A Monoclonal Anti-HMGB1 Antibody Attenuates Neurodegeneration in an Experimental Animal Model of Glaucoma.

Henrik Tonner, Selina Hunn, Nadine Auler

Pageof 2

Frequent Collaborators

4 joint publications

Johannes Graumann

2 joint publications

Katharina Bell

2 joint publications

Carsten Schmelter

1 joint publications

Thomas Münzel